Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(215)
•••
Comment by AngelMan92on Jul 13, 2020 12:47pm
80 Views
Post# 31261035

RE:RE:I've learned alot :))

RE:RE:I've learned alot :))Q2 should be around then too :))
LithLover wrote: Don't forget there is an agm on Aug 17.  Tripp will be providing a lot of information just before or at the AGM, than I expect a nice rise between Aug and Nov when Q3 comes out.  People can get in at this level or much higher next month.  Either way I expect we see new highs very soon.
AngelMan92 wrote: I hope this is an amazing week for all of us, I don't regret coming on here because now I have a better picture of what to expect with this company :)) Q2 should still show good improvement, Q3 will be orgasmic. I am willing to wait for a good movement, and this just gives me more time to buy in before boom :D I need to learn to get off here and use my time elsewhere, so let's have a good week everyone, the hype and the backing is evident by both stockhouse's and the TSX's ranking.




Bullboard Posts
Dealroom for high-potential pre-IPO opportunities